The Role of Astrocytes and Blood–Brain Barrier Disruption in Alzheimer’s Disease
Open Access
Abstract
The blood–brain barrier (BBB) is a highly intricate neurovascular structure that plays a crucial role in maintaining neural homeostasis by selectively allowing certain molecules to enter the central nervous system (CNS). However, in the context of Alzheimer’s Disease (AD), a progressive neurodegenerative disorder characterized by a gradual decline in cognitive function, the BBB’s functionality becomes impaired. This impairment leads to the breakdown of the barrier and disrupts its ability to regulate molecular transport effectively. Consequently, cellular infiltration into the CNS occurs, along with aberrant signaling and clearance of molecules, ultimately contributing to neurological deficits. One of the key factors implicated in the failure of amyloid-beta (Aβ) transport, a hallmark of AD, is the decreased expression of low-density lipoprotein receptor-related protein 1 (LRP1). LRP1 plays a crucial role in facilitating the transport of Aβ across the BBB. Additionally, the increased levels of the receptor for advanced glycation end products (RAGE) further contribute to the deregulation of the BBB in AD. These molecular imbalances significantly impact Aβ clearance and contribute to the development and progression of AD. In this review, we aimed to summarize the critical aspects of Aβ transporters in the BBB that become dysfunctional during the pathogenesis of AD.Keywords
Funding Information
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
This publication has 87 references indexed in Scilit:
- Homeostatic function of astrocytes: Ca2+ and Na+ signallingTranslational Neuroscience, 2012
- A multimodal RAGE-specific inhibitor reduces amyloid β–mediated brain disorder in a mouse model of Alzheimer diseaseJournal of Clinical Investigation, 2012
- The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β1−40 peptideNature Structural & Molecular Biology, 2011
- Neuroinflammatory processes in Alzheimer’s diseaseJournal of Neural Transmission, 2010
- SRF and myocardin regulate LRP-mediated amyloid-β clearance in brain vascular cellsNature Cell Biology, 2008
- Reduced cerebral glucose metabolism in patients at risk for Alzheimer's diseasePsychiatry Research: Neuroimaging, 2007
- Transport Pathways for Clearance of Human Alzheimer's Amyloid β-Peptide and Apolipoproteins E and J in the Mouse Central Nervous SystemJournal of Cerebral Blood Flow & Metabolism, 2007
- The glutamate/GABA‐glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transferJournal of Neurochemistry, 2006
- Astrocyte–endothelial interactions at the blood–brain barrierNature Reviews Neuroscience, 2006
- An Attenuated Immune Response Is Sufficient to Enhance Cognition in an Alzheimer's Disease Mouse Model Immunized with Amyloid-β DerivativesJournal of Neuroscience, 2004